bpc-157 infiniwell with Cognizin® - Chocolates BPC-157 Original 60c | InfiniWell

Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent

The wrong size can impact medication delivery, patient safety, and overall treatment outcomes

van der Vaart A, et al

That's by design peptide therapy should be prescribed, dosed, and monitored by someone who understands what they're doing